We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,266 hedge funds and large institutions have $176B invested in Thermo Fisher Scientific in 2022 Q3 according to their latest regulatory filings, with 116 funds opening new positions, 927 increasing their positions, 863 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 116 | Existing positions closed: 102

13% more call options, than puts

Call options by funds: $1.47B | Put options by funds: $1.3B

7% more repeat investments, than reductions

Existing positions increased: 927 | Existing positions reduced: 863

0.97% more ownership

Funds ownership: 87.64%88.62% (+0.97%)

1% less funds holding

Funds holding: 2,2812,266 (-15)

5% less capital invested

Capital invested by funds: $186B → $176B (-$9.79B)

6% less funds holding in top 10

Funds holding in top 10: 253238 (-15)

Holders
2,266
Holders Change
-15
Holders Change %
-0.66%
% of All Funds
39.04%
Holding in Top 10
238
Holding in Top 10 Change
-15
Holding in Top 10 Change %
-5.93%
% of All Funds
4.1%
New
116
Increased
927
Reduced
863
Closed
102
Calls
$1.47B
Puts
$1.3B
Net Calls
+$166M
Net Calls Change
+$177M
Name Holding Trade Value Shares
Change
Change in
Stake
CNB
901
Camden National Bank
Maine
$3.74M +$24.6K +44 +0.6%
HCA
902
Horan Capital Advisors
Ohio
$3.74M +$104K +185 +3%
NSLI
903
Nan Shan Life Insurance
Taiwan
$3.73M -$37.1M -66,235 -90%
MGP
904
Metis Global Partners
California
$3.69M +$342K +612 +9%
MAM
905
Meeder Asset Management
Ohio
$3.68M +$193K +344 +5%
ECM
906
EagleClaw Capital Management
Massachusetts
$3.64M -$42K -75 -1%
LCS
907
Levin Capital Strategies
New York
$3.64M +$163K +292 +4%
Koshinski Asset Management
908
Koshinski Asset Management
Illinois
$3.63M +$140K +251 +4%
TCA
909
Transcend Capital Advisors
New Jersey
$3.6M +$73.3K +131 +2%
KFBMI
910
Kentucky Farm Bureau Mutual Insurance
Kentucky
$3.55M
KCM
911
Kornitzer Capital Management
Kansas
$3.52M -$4.48K -8 -0.1%
PI
912
PEAK6 Investments
Illinois
$3.51M +$1.54M +2,747 +66%
IIM
913
Ipswich Investment Management
Massachusetts
$3.49M -$119K -212 -3%
JSMC
914
Jess S. Morgan & Co
California
$3.47M +$49.8K +89 +1%
SBL
915
Sargent Bickham Lagudis
Colorado
$3.44M +$9.51K +17 +0.3%
FRA
916
Front Row Advisors
California
$3.44M -$29.7K -53 -0.8%
CB
917
Cadence Bank
Mississippi
$3.44M +$3.79M +6,780 New
EVM
918
Evelyn V. Moreno
$3.43M +$124K +221 +3%
B
919
Bailard
California
$3.4M +$3.36K +6 +0.1%
AT
920
American Trust
Kentucky
$3.4M +$297K +531 +9%
CS
921
Comerica Securities
Michigan
$3.38M -$111K -199 -3%
HW
922
Hedeker Wealth
Illinois
$3.37M +$1.3M +2,328 +54%
RIM
923
Regent Investment Management
Kentucky
$3.37M +$28K +50 +0.8%
JIC
924
Johnson Investment Counsel
Ohio
$3.37M +$91.2K +163 +3%
BZWA
925
Blue Zone Wealth Advisors
California
$3.36M +$20.1K +36 +0.5%

TMO Hedge Fund Activity: Q3 2022 in Review

2,266 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2022, worth a combined $176B — down 5.3% from $186B a quarter earlier.

Buyers outnumbered sellers: 116 funds opened new TMO positions and 102 closed out — a net gain of 14 holders — while 927 added to existing stakes and 863 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $795M. The largest seller was T. Rowe Price Associates, cutting an estimated $2.12B.

  • 2,266 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2022, down from 2,281 in Q2 2022.
  • Funds reported $176B of Thermo Fisher Scientific stock for Q3 2022, down 5.3% quarter-over-quarter.
  • 116 funds opened new Thermo Fisher Scientific positions in Q3 2022 and 102 closed out, a net change of +14 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2022 was Janus Henderson Group, an estimated $795M added.
  • The largest Thermo Fisher Scientific seller in Q3 2022 was T. Rowe Price Associates, an estimated $2.12B sold.

Based on aggregated 13F filings for Q3 2022.